Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Semaphorin-6C is a type I transmembrane glycoprotein and a member of the semaphorin family, which is broadly involved in axon guidance and neuronal development[1][2][3][4][8]. It binds to plexin A receptors and is implicated in guiding proprioceptive peripheral neurons, acting primarily as a repellent signal to direct axonal growth away from certain regions, and serves as a 'stop' signal for dorsal root ganglion neurons[1][2][4][8]. It is expressed developmentally in the central and peripheral nervous system, and is thought to play roles in the regulation of neural circuit formation, maintenance, and neural regeneration following injury[1][2][3][8]. SEMA6C has been associated with conditions such as cone-rod dystrophy and lipoid proteinosis[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Semaphorin-6C (SEMA6C).